Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Language and Cognition01:27

Language and Cognition

Language serves as a bridge between ideas and communication, influencing how individuals perceive and interact with the world. Psychologists have long debated whether language shapes thought or vice versa. This discussion gained grip with Edward Sapir and Benjamin Lee Whorf in the 1940s, who proposed that language determines thought, a concept known as linguistic determinism. They suggested that the vocabulary and structure of a language influence how its speakers think and perceive reality.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Digital profiling of dysarthria in late- and early-onset Parkinson's disease.

Journal of Parkinson's disease·2026
Same author

SteuerLLM: local specialized large language model for German tax law analysis.

Scientific reports·2026
Same author

Inferring and evaluating network medicine-based disease modules with nextflow.

Bioinformatics (Oxford, England)·2026
Same author

Pushing the boundaries of robotic computed tomography: automated twin-robot CT scan with maximum reachability.

Scientific reports·2026
Same author

Synthesizing vocal tract magnetic resonance imaging sequences with phoneme-aware diffusion models.

Journal of medical imaging (Bellingham, Wash.)·2026
Same author

Illuminating the black box of reservoir computing.

Scientific reports·2026

Related Experiment Video

Updated: Jul 9, 2026

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
03:14

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

Published on: December 6, 2024

Generating Alzheimer's narratives using large language models.

Paula Andrea Perez-Toro1,2, Mahmoud Almizel3, Elmar Nöth3

  • 1Pattern Recognition Lab, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany. paula.andrea.perez@fau.de.

BMC Medical Informatics and Decision Making
|July 7, 2026
PubMed
Summary

Large Language Models (LLMs) can create synthetic speech data for Alzheimer's disease (AD) assessment, improving diagnostic accuracy. This approach helps overcome data limitations in dementia research.

Keywords:
Alzheimer’s diseaseGenerative AILarge language modelsSynthetic data augmentation

More Related Videos

DeepOmicsAE: Representing Signaling Modules in Alzheimer's Disease with Deep Learning Analysis of Proteomics, Metabolomics, and Clinical Data
09:47

DeepOmicsAE: Representing Signaling Modules in Alzheimer's Disease with Deep Learning Analysis of Proteomics, Metabolomics, and Clinical Data

Published on: December 15, 2023

Related Experiment Videos

Last Updated: Jul 9, 2026

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
03:14

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

Published on: December 6, 2024

DeepOmicsAE: Representing Signaling Modules in Alzheimer's Disease with Deep Learning Analysis of Proteomics, Metabolomics, and Clinical Data
09:47

DeepOmicsAE: Representing Signaling Modules in Alzheimer's Disease with Deep Learning Analysis of Proteomics, Metabolomics, and Clinical Data

Published on: December 15, 2023

Area of Science:

  • Computational linguistics
  • Artificial intelligence in healthcare
  • Neuroscience

Background:

  • Semi-spontaneous speech analysis shows promise for Alzheimer's disease (AD) assessment.
  • Clinical data scarcity currently limits progress in AD assessment using speech.
  • Large Language Models (LLMs) offer a novel approach to generate synthetic speech data.

Purpose of the Study:

  • To evaluate the ability of various LLMs (GPT, T5/Flan-T5, LLaMA, Mistral, Qwen) to generate clinically plausible narratives for AD assessment.
  • To assess synthetic narrative quality using automated metrics and human expert ratings.
  • To determine the impact of LLM-generated data on AD classification model performance.

Main Methods:

  • LLMs were fine-tuned on the DementiaBank Pitt Corpus.
  • Two configurations were tested: Human-to-Bot and Bot-to-Bot interactions.
  • Generated narratives were evaluated using lexical/semantic metrics, human ratings, and for augmenting a BERT-based AD classifier.

Main Results:

  • Mistral, LLaMA, and Qwen demonstrated superior performance in generating fluent, plausible, and diagnostically informative narratives.
  • LLM-generated data augmented classifier training achieved a higher F1-score (0.84) compared to real data alone (0.74).
  • Human-to-Bot synthetic data yielded the most significant diagnostic improvements, while Bot-to-Bot data showed less clinical realism.

Conclusions:

  • LLMs can generate high-quality synthetic narratives for cognitive assessment, enhancing AD classification.
  • LLM-generated data offers a scalable solution to data scarcity in dementia research.
  • Future research should focus on improving synthetic dialogue quality and evaluation frameworks for clinical relevance.